AMDF: American Macular Degeneration Foundation

Double Issue Nos. 34 & 35

We interpret the latest scientific information about macular degeneration, and, when applicable, offer simple, helpful guidelines that can be easily incorporated into your every day life.
Interviews with ophthalmologists, researchers, nutritionists and others.
Printed in large type.
Pre-punched for easy storage in a three-ring binder for quick future reference.
With a donation of $25.00 ($45.00 Foreign) or more, you will receive four issues of the AMDF Quarterly Newsletter. Your donation promotes the AMDF's education and research goals.

IN THIS ISSUE

Important information for everyone!

Interview with Johanna M. Seddon, M.D., Sc.M., who has been studying age-related macular degeneration for 20 years and is a leader in the field of AMD research.
Genentech restricts the use of its cancer drug for the treatment of “wet” form of AMD.
High glucose concentrations may raise risk of developing macular degeneration.
In the UK, National Health limits use of Lucentis.
VIEW 1 study seeking participants.
Opko Health enrolling patients in Phase 3 trial.

AMDF DVD Hope & Cope - Living with Macular Degeneration
free with new subscription.

Previous issues of the AMDF Quarterly Newsletter are available for
$10.00 each ($15.00 Foreign).

The Newsletter makes a thoughtful gift too!

If you wish to mail your contribution to the AMDF,
you may complete a printable form or
you may use our secure online form to send your donation to us.

American Macular Degeneration Foundation
P.O. Box 515
Northampton, MA 01061-0515
(413) 268-7660

Email
Privacy Policy

AMDF Newsletter — In the Spotlight

The Newsletter makes a thoughtful gift too!